These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 33237558)
1. CYP2C19 Genotype-Guided Antiplatelet Therapy Among Asian Patients with Ischaemic Stroke. Kow CS; Zaihan AF; Hasan SS Clin Drug Investig; 2021 Jan; 41(1):115-116. PubMed ID: 33237558 [No Abstract] [Full Text] [Related]
2. Influence of Genetic Polymorphisms on Clopidogrel Response and Clinical Outcomes in Patients with Acute Ischemic Stroke CYP2C19 Genotype on Clopidogrel Response. Han Y; Lv HH; Liu X; Dong Q; Yang XL; Li SX; Wu S; Jiang JM; Luo Z; Zhu DS; Zhang Y; Zheng Y; Guan YT; Xu JF CNS Neurosci Ther; 2015 Sep; 21(9):692-7. PubMed ID: 26177117 [TBL] [Abstract][Full Text] [Related]
3. Dual therapy with clopidogrel and aspirin prevents early neurological deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles. Lin J; Han Z; Wang C; Yi X; Chai Z; Zhou Q; Huang R Eur J Clin Pharmacol; 2018 Sep; 74(9):1131-1140. PubMed ID: 29804161 [TBL] [Abstract][Full Text] [Related]
4. Aspirin plus clopidogrel may reduce the risk of early neurologic deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles. Yi X; Zhou Q; Wang C; Lin J; Chai Z J Neurol; 2018 Oct; 265(10):2396-2403. PubMed ID: 30128710 [TBL] [Abstract][Full Text] [Related]
5. Protocol for the comparison of triflusal and clopidogrel in secondary prevention of stroke based on cytochrome P450 2C19 genotyping (MASETRO study): A multicenter, randomized, open-label, parallel-group trial. Han SW; Kim YJ; Ahn SH; Seo WK; Yu S; Oh SH; Kim YN; Lee KY; Int J Stroke; 2016 Jun; 11(4):485-91. PubMed ID: 26763917 [TBL] [Abstract][Full Text] [Related]
6. Influence of CYP2C19 polymorphisms on platelet reactivity and clinical outcomes in ischemic stroke patients treated with clopidogrel. Qiu LN; Sun Y; Wang L; Han RF; Xia XS; Liu J; Li X Eur J Pharmacol; 2015 Jan; 747():29-35. PubMed ID: 25489921 [TBL] [Abstract][Full Text] [Related]
7. Variants in clopidogrel-relevant genes and early neurological deterioration in ischemic stroke patients receiving clopidogrel. Yi X; Zhou Q; Zhang Y; Zhou J; Lin J BMC Neurol; 2020 Apr; 20(1):159. PubMed ID: 32345264 [TBL] [Abstract][Full Text] [Related]
8. Association with CYP2C19 polymorphisms and Clopidogrel in treatment of elderly stroke patients. Li C; Jia W; Li J; Li F; Ma J; Zhou L BMC Neurol; 2021 Mar; 21(1):104. PubMed ID: 33685396 [TBL] [Abstract][Full Text] [Related]
9. Concomitant Use of Proton Pump Inhibitors and Clopidogrel Is Not Associated with Adverse Outcomes after Ischemic Stroke in Chinese Population. Yi X; Zhou Q; Wang C; Lin J; Cheng W; Chi L J Stroke Cerebrovasc Dis; 2016 Dec; 25(12):2859-2867. PubMed ID: 27546731 [TBL] [Abstract][Full Text] [Related]
10. Effect of CYP2C19*2 and *3 on clinical outcome in ischemic stroke patients treated with clopidogrel. Wang Y; Cai H; Zhou G; Zhang Z; Liu X J Neurol Sci; 2016 Oct; 369():216-219. PubMed ID: 27653892 [TBL] [Abstract][Full Text] [Related]
11. Reply to effect of CYP2C19*2 and *3 on clinical outcome in ischemic stroke patients treated with Clopidogrel. Moris D; Bakoyiannis C; Karaolanis G; Georgopoulos S J Neurol Sci; 2017 Jan; 372():464. PubMed ID: 27823837 [No Abstract] [Full Text] [Related]
12. Clopidogrel responder status is uninfluenced by CYP2C19*2 in Danish patients with stroke. Rath CL; Jørgensen NR; Wienecke T PLoS One; 2020; 15(12):e0236260. PubMed ID: 33370281 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness and safety of high dose clopidogrel plus aspirin in ischemic stroke patients with the single CYP2C19 loss-of-function allele: a randomized trial. Wu H; Song H; Dou L; Gao B; Pan Y; Dong M; Chen Q; Li J; Song L; Liu C; Li B; Chu W BMC Neurol; 2020 Oct; 20(1):395. PubMed ID: 33121452 [TBL] [Abstract][Full Text] [Related]
14. Genotype-guided antiplatelet therapy compared with conventional therapy for patients with acute coronary syndromes: a systematic review and meta-analysis. Zheng L; Yang C; Xiang L; Hao Z Biomarkers; 2019 Sep; 24(6):517-523. PubMed ID: 31215825 [TBL] [Abstract][Full Text] [Related]
16. Association of Cytochrome P450 Genetic Variants with Clopidogrel Resistance and Outcomes in Acute Ischemic Stroke. Yi X; Lin J; Wang Y; Zhou Q; Wang C; Cheng W; Chi L J Atheroscler Thromb; 2016 Oct; 23(10):1188-1200. PubMed ID: 26961113 [TBL] [Abstract][Full Text] [Related]
17. CYP2C19 and CES1 polymorphisms and efficacy of clopidogrel and aspirin dual antiplatelet therapy in patients with symptomatic intracranial atherosclerotic disease. Hoh BL; Gong Y; McDonough CW; Waters MF; Royster AJ; Sheehan TO; Burkley B; Langaee TY; Mocco J; Zuckerman SL; Mummareddy N; Stephens ML; Ingram C; Shaffer CM; Denny JC; Brilliant MH; Kitchner TE; Linneman JG; Roden DM; Johnson JA J Neurosurg; 2016 Jun; 124(6):1746-51. PubMed ID: 26587656 [TBL] [Abstract][Full Text] [Related]
18. Antiplatelet effect of ticagrelor with aspirin in acute minor stroke and transient ischemic attack stratified by Zhou M; Chen W; Pan Y; Lin Y; Meng X; Zhao X; Liu L; Lin J; Li H; Wang Y; Wang Y Aging (Albany NY); 2020 Dec; 13(3):3994-4006. PubMed ID: 33411687 [TBL] [Abstract][Full Text] [Related]
19. CYP2C19 metabolizer status and clopidogrel efficacy in the Secondary Prevention of Small Subcortical Strokes (SPS3) study. McDonough CW; McClure LA; Mitchell BD; Gong Y; Horenstein RB; Lewis JP; Field TS; Talbert RL; Benavente OR; Johnson JA; Shuldiner AR J Am Heart Assoc; 2015 May; 4(6):e001652. PubMed ID: 26019129 [TBL] [Abstract][Full Text] [Related]
20. Concomitant Use of Proton-Pump Inhibitors and Clopidogrel Increases the Risk of Adverse Outcomes in Patients With Ischemic Stroke Carrying Reduced-Function CYP2C19*2. Yi X; Han Z; Zhou Q; Cheng W; Lin J; Wang C Clin Appl Thromb Hemost; 2018 Jan; 24(1):55-62. PubMed ID: 27637911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]